Business Context and Reporting Period
This Form 8-K is filed by Flex Pharma, Inc. (not Decoy Therapeutics Inc.) on November 4, 2015. The report announces the financial results for the quarter ended September 30, 2015. The filing incorporates a press release as Exhibit 99.1 but does not contain the detailed financial data within the text of the 8-K itself.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained in the attached press release (Exhibit 99.1), which is referenced but not included in the provided source text.
Material Changes
No material changes versus the prior comparable period are described in the text of this filing. The document serves solely as a notification that results have been issued.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It explicitly states that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the correct registrant name is Flex Pharma, Inc., as the input metadata referenced Decoy Therapeutics Inc.
- Locate and review Exhibit 99.1 (the press release) to obtain actual financial figures for the quarter ended September 30, 2015.
- Confirm the specific details of the financial results, as the 8-K text only announces their release without providing data.